HIGHLIGHTS
- who: Damiano Bartolucci and collaborators from the Department of Pharmacy and Biotechnology, University of Bologna, Bologna, Italy have published the paper: Precision Anti-Cancer Medicines by Oligonucleotide Therapeutics in Clinical Research Targeting Undruggable Proteins and Non-Coding RNAs, in the Journal: Pharmaceutics 2022, 14, 1453. of 30/05/2022
- what: In this context this review describes how the oligonucleotide therapeutics RNA or DNA sequences are emerging as a new class of drugs able to tackle the limitations described above. The analysis shows how they are the subject of almost the same number of clinical trials . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.